Design and Evaluation of a CDSS for Drug Allergy Management Using LLMs and Pharmaceutical Data Integration

• URL: http://arxiv.org/abs/2409.16395v1
• Date: Tue, 24 Sep 2024 18:55:10 GMT
• Title: Design and Evaluation of a CDSS for Drug Allergy Management Using LLMs and Pharmaceutical Data Integration
• Authors: Gabriele De Vito, Filomena Ferrucci, Athanasios Angelakis,
• Abstract summary: Heliot is an innovative CDSS for drug allergy management. It integrates Large Language Models (LLMs) with a comprehensive pharmaceutical data repository. Heliot's high accuracy, precision, recall, and F1 score, uniformly reaching 100% across multiple experimental runs.
• Score: 3.2627279988912194
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Medication errors significantly threaten patient safety, leading to adverse drug events and substantial economic burdens on healthcare systems. Clinical Decision Support Systems (CDSSs) aimed at mitigating these errors often face limitations, including reliance on static databases and rule-based algorithms, which can result in high false alert rates and alert fatigue among clinicians. This paper introduces HELIOT, an innovative CDSS for drug allergy management, integrating Large Language Models (LLMs) with a comprehensive pharmaceutical data repository. HELIOT leverages advanced natural language processing capabilities to interpret complex medical texts and synthesize unstructured data, overcoming the limitations of traditional CDSSs. An empirical evaluation using a synthetic patient dataset and expert-verified ground truth demonstrates HELIOT's high accuracy, precision, recall, and F1 score, uniformly reaching 100\% across multiple experimental runs. The results underscore HELIOT's potential to enhance decision support in clinical settings, offering a scalable, efficient, and reliable solution for managing drug allergies.

Related papers

• AIPatient: Simulating Patients with EHRs and LLM Powered Agentic Workflow [33.8495939261319]
  We develop an advanced simulated patient system with AIPatient Knowledge Graph (AIPatient KG) as the input and Reasoning Retrieval-Augmented Generation (Reasoning RAG) as the generation backbone. Reasoning RAG leverages six LLM powered agents spanning tasks including retrieval, KG query generation, abstraction, checker, rewrite, and summarization. Our system also presents high readability (median Flesch Reading Ease 77.23; median Flesch Kincaid Grade 5.6), robustness (ANOVA F-value 0.6126, p>0.1), and stability (ANOVA F-value 0.782, p>0.1)
  arXiv  Detail & Related papers  (2024-09-27T17:17:15Z)
• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [57.067409211231244]
  This paper presents meticulously curated AIready datasets covering multi-modal data (e.g., drug molecule, disease code, text, categorical/numerical features) and 8 crucial prediction challenges in clinical trial design. We provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• Binary Gaussian Copula Synthesis: A Novel Data Augmentation Technique to Advance ML-based Clinical Decision Support Systems for Early Prediction of Dialysis Among CKD Patients [4.80104397397529]
  The Center for Disease Control estimates that over 37 million US adults suffer from chronic kidney disease (CKD) 9 out of 10 of these individuals are unaware of their condition due to the absence of symptoms in the early stages. Early prediction of dialysis is crucial as it can significantly improve patient outcomes.
  arXiv  Detail & Related papers  (2024-03-01T20:32:17Z)
• Mixed-Integer Projections for Automated Data Correction of EMRs Improve Predictions of Sepsis among Hospitalized Patients [7.639610349097473]
  We introduce an innovative projections-based method that seamlessly integrates clinical expertise as domain constraints. We measure the distance of corrected data from the constraints defining a healthy range of patient data, resulting in a unique predictive metric we term as "trust-scores" We show an AUROC of 0.865 and a precision of 0.922, that surpasses conventional ML models without such projections.
  arXiv  Detail & Related papers  (2023-08-21T15:14:49Z)
• Large Language Models for Healthcare Data Augmentation: An Example on Patient-Trial Matching [49.78442796596806]
  We propose an innovative privacy-aware data augmentation approach for patient-trial matching (LLM-PTM) Our experiments demonstrate a 7.32% average improvement in performance using the proposed LLM-PTM method, and the generalizability to new data is improved by 12.12%.
  arXiv  Detail & Related papers  (2023-03-24T03:14:00Z)
• SPeC: A Soft Prompt-Based Calibration on Performance Variability of Large Language Model in Clinical Notes Summarization [50.01382938451978]
  We introduce a model-agnostic pipeline that employs soft prompts to diminish variance while preserving the advantages of prompt-based summarization. Experimental findings indicate that our method not only bolsters performance but also effectively curbs variance for various language models.
  arXiv  Detail & Related papers  (2023-03-23T04:47:46Z)
• Transformer-based unsupervised patient representation learning based on medical claims for risk stratification and analysis [3.5492837081144204]
  Transformer-based Multimodal AutoEncoder (TMAE) can learn efficient patient representation by encoding meaningful information from the claims data. We trained TMAE using a real-world pediatric claims dataset containing more than 600,000 patients.
  arXiv  Detail & Related papers  (2021-06-23T21:29:50Z)
• Clinical Outcome Prediction from Admission Notes using Self-Supervised Knowledge Integration [55.88616573143478]
  Outcome prediction from clinical text can prevent doctors from overlooking possible risks. Diagnoses at discharge, procedures performed, in-hospital mortality and length-of-stay prediction are four common outcome prediction targets. We propose clinical outcome pre-training to integrate knowledge about patient outcomes from multiple public sources.
  arXiv  Detail & Related papers  (2021-02-08T10:26:44Z)
• SDF-Bayes: Cautious Optimism in Safe Dose-Finding Clinical Trials with Drug Combinations and Heterogeneous Patient Groups [84.63561578944183]
  This paper proposes a novel Bayesian design, SDF-Bayes, for finding the maximum tolerated dose (MTD) of a drug in a clinical trial. Rather than the conventional principle of escalating or de-escalating the current dose of one drug, SDF-Bayes proceeds by cautious optimism. Extensive experiments based on both synthetic and real-world datasets demonstrate the advantages of SDF-Bayes over state of the art DC trial designs.
  arXiv  Detail & Related papers  (2021-01-26T18:59:26Z)
• EVA: Generating Longitudinal Electronic Health Records Using Conditional Variational Autoencoders [34.22731849545798]
  We propose EHR Variational Autoencoder (EVA) for synthesizing sequences of discrete EHR encounters and encounter features. We illustrate that EVA can produce realistic sequences, account for individual differences among patients, and can be conditioned on specific disease conditions. We assess the utility of the methods on large real-world EHR repositories containing over 250, 000 patients.
  arXiv  Detail & Related papers  (2020-12-18T02:37:49Z)
• Learning for Dose Allocation in Adaptive Clinical Trials with Safety Constraints [84.09488581365484]
  Phase I dose-finding trials are increasingly challenging as the relationship between efficacy and toxicity of new compounds becomes more complex. Most commonly used methods in practice focus on identifying a Maximum Tolerated Dose (MTD) by learning only from toxicity events. We present a novel adaptive clinical trial methodology that aims at maximizing the cumulative efficacies while satisfying the toxicity safety constraint with high probability.
  arXiv  Detail & Related papers  (2020-06-09T03:06:45Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.